A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Jazz Pharmaceuticals
Jazz Pharmaceuticals
AstraZeneca
Hoffmann-La Roche
Baylor College of Medicine
University of Nebraska
VM Oncology, LLC
Cancer Research UK
Bayer
LigaChem Biosciences, Inc.
University of Colorado, Denver
Merck Sharp & Dohme LLC
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
OncoC4, Inc.
Thomas Jefferson University
Taproot Health
Convalife (Shanghai) Co., Ltd.
Universitair Ziekenhuis Brussel
Hoffmann-La Roche
Klus Pharma Inc.
Eastern Cooperative Oncology Group
Xencor, Inc.
MacroGenics
AIDS Malignancy Consortium
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
Vanderbilt University Medical Center
Stanford University
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
University of Arizona
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)